Carlos Neto - Diagnsticos Chief Director
| DASA3 Stock | BRL 2.24 0.06 2.61% |
Insider
Carlos Neto is Chief Director of Diagnsticos da Amrica
| Phone | 55 11 4197 5500 |
| Web | https://www.dasa3.com.br |
Diagnsticos Management Efficiency
The company has return on total asset (ROA) of 0.0224 % which means that it generated a profit of $0.0224 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0458) %, meaning that it generated substantial loss on money invested by shareholders. Diagnsticos' management efficiency ratios could be used to measure how well Diagnsticos manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Flavio Prieto | Gafisa SA | N/A | |
| Sheyla Resende | Gafisa SA | 37 | |
| Octavio Lazari | Odontoprev SA | 56 | |
| Luis Ortiz | Gafisa SA | 45 | |
| Antnio Filho | CCR SA | 59 | |
| Jos Pacheco | Odontoprev SA | 62 | |
| Renato Costa | Odontoprev SA | 32 | |
| Giselia Silva | CPFL Energia SA | N/A | |
| Marcus Macedo | CCR SA | N/A | |
| Flavio Ribeiro | CPFL Energia SA | 42 | |
| Waldo Leskovar | CCR SA | 55 | |
| Joao CFA | Rossi Residencial SA | 52 | |
| Gustavo Lopes | CCR SA | N/A | |
| Rodrigo Osmo | Gafisa SA | 46 | |
| Pedro Sutter | CCR SA | 53 | |
| Srgio Felice | CPFL Energia SA | N/A | |
| Rodrigo Bacellar | Odontoprev SA | 57 | |
| Luiz Cappi | Odontoprev SA | 75 | |
| Guilherme Benevides | Gafisa SA | 42 | |
| Vitor Filho | Rossi Residencial SA | 52 | |
| Marcio Hannas | CCR SA | 54 | |
Management Performance
| Return On Equity | -0.0458 | |||
| Return On Asset | 0.0224 |
Diagnsticos da Amrica Leadership Team
Elected by the shareholders, the Diagnsticos' board of directors comprises two types of representatives: Diagnsticos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Diagnsticos. The board's role is to monitor Diagnsticos' management team and ensure that shareholders' interests are well served. Diagnsticos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Diagnsticos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ricardo Orlando, Chief Information Technology | ||
| Octavio Silva, Member of the Executive Board, Vice President of Operations | ||
| Pedro Bueno, Chief Executive Officer, Director | ||
| Ricardo SIlva, Private and Hospitals Businesses Officer | ||
| Emerson Gasparetto, Radiology and Graphic Methods Officer, Member of the Executive Board | ||
| Carlos Neto, Chief Director | ||
| Linaldo Junior, Chief Officer | ||
| Adriano Lima, Executive Vice President of Human Resources | ||
| Fbio Cunha, Chief Officer | ||
| Felipe Guimaraes, Chief Officer |
Diagnsticos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Diagnsticos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0458 | |||
| Return On Asset | 0.0224 | |||
| Profit Margin | (0.03) % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 17.24 B | |||
| Shares Outstanding | 557.11 M | |||
| Shares Owned By Insiders | 56.27 % | |||
| Shares Owned By Institutions | 33.62 % | |||
| Price To Earning | 63.21 X | |||
| Price To Book | 1.00 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Diagnsticos Stock Analysis
When running Diagnsticos' price analysis, check to measure Diagnsticos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diagnsticos is operating at the current time. Most of Diagnsticos' value examination focuses on studying past and present price action to predict the probability of Diagnsticos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diagnsticos' price. Additionally, you may evaluate how the addition of Diagnsticos to your portfolios can decrease your overall portfolio volatility.